Glynn Capital Management Exits Klaviyo Position Before Earnings Drop
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 4 hours ago
0mins
Should l Buy KVYO?
Source: Yahoo Finance
- Exit Transaction: Glynn Capital Management sold all 456,805 shares of Klaviyo in Q1 2026, with an estimated transaction value of $9.80 million, reflecting a cautious stance on market prospects.
- Value Decline: The sale and stock price movement resulted in a $14.83 million decline in Glynn's Klaviyo position value, indicating the company's unfavorable performance in the market.
- Performance Discrepancy: Despite Klaviyo's revenue increasing by 28% year-over-year to $358 million and non-GAAP operating income nearly doubling to $58.6 million, the stock plummeted 32% post-earnings, highlighting valuation pressures.
- Future Outlook: Klaviyo still holds nearly $985 million in cash, and despite stock volatility, long-term investors may find the current low price point offers a more attractive investment opportunity.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy KVYO?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on KVYO
Wall Street analysts forecast KVYO stock price to rise
17 Analyst Rating
17 Buy
0 Hold
0 Sell
Strong Buy
Current: 15.770
Low
35.00
Averages
42.40
High
46.00
Current: 15.770
Low
35.00
Averages
42.40
High
46.00
About KVYO
Klaviyo, Inc. provides a customer relationship management (CRM) platform for business-to-consumer (B2C) brands. The Company, through its built-in data platform and artificial intelligence (AI) insights, combines marketing automation, analytics, and customer service into one unified solution, making it easy for businesses to know their customers. The Company’s marketing automation solution allows customers to orchestrate campaigns across multiple marketing channels including email, short message service and mobile push. Its platform solutions include Klaviyo B2C CRM, Klaviyo Marketing, Klaviyo Service, Klaviyo Analytics, Klaviyo Data Platform, and Klaviyo AI. The Klaviyo B2C CRM is a platform built for consumer brands. Its platform serves businesses of all sizes, across industries and geographies. Its platform solution also includes Gatsby, a social automation product that helps brands convert engagement over social channels into owned customer relationships.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Exit Transaction: Glynn Capital Management sold all 456,805 shares of Klaviyo in Q1, with an estimated transaction value of $9.80 million, reflecting a cautious outlook on market conditions.
- Position Change: This sale reduced Glynn Capital's position in Klaviyo to zero, resulting in a $14.83 million decline in portfolio value, indicating a significant loss of confidence in the company.
- Performance Discrepancy: Despite Klaviyo reporting a 28% year-over-year revenue increase to $358 million, the stock plummeted 32% following the earnings report on May 5, suggesting that market expectations were overly optimistic.
- Cash Flow Status: Klaviyo still holds nearly $985 million in cash, and despite facing valuation pressures and uncertainty from the CFO's resignation, its improving margins and strong customer retention rates present potential opportunities for long-term investors.
See More
- Exit Transaction: Glynn Capital Management sold all 456,805 shares of Klaviyo in Q1 2026, with an estimated transaction value of $9.80 million, reflecting a cautious stance on market prospects.
- Value Decline: The sale and stock price movement resulted in a $14.83 million decline in Glynn's Klaviyo position value, indicating the company's unfavorable performance in the market.
- Performance Discrepancy: Despite Klaviyo's revenue increasing by 28% year-over-year to $358 million and non-GAAP operating income nearly doubling to $58.6 million, the stock plummeted 32% post-earnings, highlighting valuation pressures.
- Future Outlook: Klaviyo still holds nearly $985 million in cash, and despite stock volatility, long-term investors may find the current low price point offers a more attractive investment opportunity.
See More
- Share Sale Details: Glynn Capital sold 456,805 shares of Klaviyo in Q1, with an estimated transaction value of $9.80 million, showcasing the fund's strategic timing in response to market conditions.
- Asset Management Impact: This sale resulted in a $14.83 million decline in the value of Glynn Capital's position in Klaviyo, indicating a weakening market confidence that adversely affected the fund's overall assets under management.
- Performance Reaction: Klaviyo's earnings report on May 5 revealed a 28% year-over-year revenue increase to $358 million; however, the stock plummeted 32%, highlighting investor concerns over valuation despite strong financial results.
- Future Outlook: While Klaviyo maintains nearly $985 million in cash and strong customer retention metrics, the market's diminished growth expectations necessitate a cautious approach for potential investors considering the stock's recent volatility.
See More
- Agentic Marketing Workflows: Klaviyo's integration with Anthropic's Claude enables brands to quickly generate marketing reports and insights through natural language, significantly enhancing customer data processing efficiency and allowing brands to respond faster to customer needs in a competitive market.
- Data-Driven Decision Making: The new Klaviyo MCP connector allows brands to securely access critical data across the customer lifecycle, enabling marketing teams to generate performance summaries and customer segments in real-time, reducing manual reporting time and improving decision accuracy.
- Automated Workflows: The introduction of Claude Cowork allows marketers to automate document and marketing asset generation in a single session, significantly reducing repetitive workload and enhancing productivity, enabling teams to focus more on strategic tasks.
- Cross-Industry Applications: Klaviyo's integration extends beyond retail, as the hospitality sector can leverage this technology to analyze customer engagement data and develop targeted re-engagement campaigns, thereby optimizing marketing strategies and supporting broader business decision-making.
See More
- Arm Holdings Surge: Ahead of its earnings report, Arm Holdings saw a nearly 13% jump on Nasdaq, with UBS analyst raising its 12-month price target from $175 to $245, indicating strong market optimism for its growth potential.
- Healthpeak Properties Strong Performance: The healthcare REIT soared 18% after first-quarter funds from operations and revenue exceeded Wall Street expectations, raising its second-quarter FFO guidance to $1.71 to $1.75, reflecting robust business momentum.
- CDW Stock Decline: CDW shares dropped 19% after reporting disappointing operating income in Q1, with adjusted EPS of $2.28 matching consensus, yet the company reaffirmed its 2026 outlook, raising concerns about future performance.
- Aurora Innovation Partnership: Aurora Innovation's stock rose 9% following a deal to provide driverless technology to Berkshire Hathaway's McLane, which is expected to enhance its competitive edge in the long-haul trucking market.
See More
- AMD Strong Guidance: AMD shares surged 20% after issuing a second-quarter revenue forecast of $11.2 billion, exceeding the analyst estimate of $10.52 billion, with first-quarter results also surpassing expectations, indicating robust performance in the semiconductor market.
- Super Micro Earnings Beat: Super Micro's stock jumped nearly 15% as fourth-quarter profit expectations range from 65 to 79 cents per share, significantly above Wall Street's call for 55 cents, with third-quarter adjusted earnings of 84 cents per share showcasing its competitiveness in the server market.
- CVS Health Performance Boost: CVS Health shares gained 4% after reporting first-quarter adjusted earnings of $2.57 per share and revenue of $100.43 billion, both exceeding analyst expectations, while the company raised its full-year earnings outlook, reflecting strong performance in the pharmacy benefits sector.
- Lucid Group Worsening Losses: Lucid Group shares fell 3% as the company reported a first-quarter loss of $3.46 per share, significantly worse than the expected loss of $2.64, with revenue of $282.5 million missing the $440.4 million target, highlighting challenges in the electric vehicle market.
See More











